Add to Favourites
To login click here
The global healthcare bioconvergence market size is expected to reach USD 215.2 billion by 2030 at a CAGR of 7.4% from 2022 to 2030. Factors driving the market growth include the growing geriatric population, rising stem cell technology, and the integration of high-tech technologies and advancements such as robotics, machine learning, intelligent imaging, ergonomics, and artificial intelligence with life science. The report covers the market size, share, and trends analysis of the healthcare bioconvergence market by application (drug discovery, regenerative medicine, bioelectronics), by region (North America, Europe, Asia Pacific), and segment forecasts, 2022 – 2030.